GlassScriptPhysician profile
Brenda J Hines
NPI 1043296015
$399.52
in general payments reported to CMS, 2019-2025
14 companies · $54.71 in 2025
The $54.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $32.10 · 2021: $40.64 · 2022: $50.66 · 2023: $50.82 · 2024: $54.88 · 2025: $54.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $82.03 | 2019-2025 | Myosure Tissue Removal Device |
| Astellas Pharma US INC | $54.88 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $44.21 | 2020-2022 | |
| Organon LLC | $41.19 | 2022-2023 | |
| Renovia INC | $28.69 | 2021 | |
| Lupin INC. | $19.63 | 2019 | |
| Abbvie INC. | $18.99 | 2019 | |
| Aspira Women'S Health INC | $18.89 | 2023 | Ova1 |
| Roche Diagnostics Corporation | $18.76 | 2019 | |
| Sumitomo Pharma America, INC. | $17.69 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $16.80 | 2019 | |
| Avanos Medical | $14.21 | 2019 | |
| Agile Therapeutics, INC. | $11.95 | 2021 | |
| Coopersurgical, INC. | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.